| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.039 | 0.3 |